{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:37:02Z","timestamp":1763555822068,"version":"3.45.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24779-x","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:32:58Z","timestamp":1763555578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Explore the key genes and prognosis related to mitochondrial permeability transition driving necrosis gene in kidney renal clear cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Yikai","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingyang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibing","family":"Shuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"24779_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio, U. et al. Epidemiology of renal cell carcinoma. Eur. Urol. 75, 74\u201384. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.036 (2019).","journal-title":"Eur. Urol."},{"key":"24779_CR2","doi-asserted-by":"publisher","unstructured":"Nabi, S., Kessler, E. R., Bernard, B., Flaig, T. W. & Lam, E. T. Renal cell carcinoma: a review of biology and pathophysiology. F1000Research  7, 307. https:\/\/doi.org\/10.12688\/f1000research.13179.1  (2018).","DOI":"10.12688\/f1000research.13179.1"},{"key":"24779_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1158\/2159-8290.Cd-19-0499","volume":"9","author":"L Vuong","year":"2019","unstructured":"Vuong, L., Kotecha, R. R., Voss, M. H. & Hakimi, A. A. Tumor microenvironment dynamics in clear-cell renal cell carcinoma. Cancer Discov. 9, 1349\u20131357. https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-0499 (2019).","journal-title":"Cancer Discov."},{"key":"24779_CR4","doi-asserted-by":"publisher","first-page":"890150","DOI":"10.3389\/fimmu.2022.890150","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Immune-Associated gene signatures serve as a promising biomarker of immunotherapeutic prognosis for renal clear cell carcinoma. Front. Immunol. 13, 890150. https:\/\/doi.org\/10.3389\/fimmu.2022.890150 (2022).","journal-title":"Front. Immunol."},{"key":"24779_CR5","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00345-018-2309-4","volume":"36","author":"T Klatte","year":"2018","unstructured":"Klatte, T., Rossi, S. H. & Stewart, G. D. Prognostic factors and prognostic models for renal cell carcinoma: a literature review. World J. Urol. 36, 1943\u20131952. https:\/\/doi.org\/10.1007\/s00345-018-2309-4 (2018).","journal-title":"World J. Urol."},{"key":"24779_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1200\/jco.2017.74.2627","volume":"36","author":"KD Courtney","year":"2018","unstructured":"Courtney, K. D. et al. Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2\u03b1 antagonist in patients with previously treated advanced clear cell renal cell carcinoma. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 36, 867\u2013874. https:\/\/doi.org\/10.1200\/jco.2017.74.2627 (2018).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"24779_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cmet.2018.04.009","volume":"27","author":"JD Ochocki","year":"2018","unstructured":"Ochocki, J. D. et al. Arginase 2 suppresses renal carcinoma progression via biosynthetic cofactor pyridoxal phosphate depletion and increased polyamine toxicity. Cell Metabol. 27, 1263\u20131280e1266. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.009 (2018).","journal-title":"Cell Metabol."},{"key":"24779_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2008.01.006","volume":"18","author":"V Gogvadze","year":"2008","unstructured":"Gogvadze, V., Orrenius, S. & Zhivotovsky, B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol. 18, 165\u2013173. https:\/\/doi.org\/10.1016\/j.tcb.2008.01.006 (2008).","journal-title":"Trends Cell Biol."},{"key":"24779_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.mito.2006.07.006","volume":"6","author":"JS Armstrong","year":"2006","unstructured":"Armstrong, J. S. The role of the mitochondrial permeability transition in cell death. Mitochondrion 6, 225\u2013234. https:\/\/doi.org\/10.1016\/j.mito.2006.07.006 (2006).","journal-title":"Mitochondrion"},{"key":"24779_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1474-9728.2003.00073.x","volume":"3","author":"M Crompton","year":"2004","unstructured":"Crompton, M. Mitochondria and aging: a role for the permeability transition? Aging Cell 3, 3\u20136. https:\/\/doi.org\/10.1046\/j.1474-9728.2003.00073.x (2004).","journal-title":"Aging Cell"},{"key":"24779_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00232-007-9006-3","volume":"215","author":"K Kupsch","year":"2007","unstructured":"Kupsch, K., Parvez, S., Siemen, D. & Wolf, G. Modulation of the permeability transition pore by Inhibition of the mitochondrial K(ATP) channel in liver vs. brain mitochondria. J. Membr. Biol. 215, 69\u201374. https:\/\/doi.org\/10.1007\/s00232-007-9006-3 (2007).","journal-title":"J. Membr. Biol."},{"key":"24779_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s10495-007-0723-y","volume":"12","author":"A Rasola","year":"2007","unstructured":"Rasola, A. & Bernardi, P. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis Int. J. Program Cell Death 12, 815\u2013833. https:\/\/doi.org\/10.1007\/s10495-007-0723-y (2007).","journal-title":"Apoptosis Int. J. Program Cell Death"},{"key":"24779_CR13","doi-asserted-by":"publisher","unstructured":"Zhang, P. et al. Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J. Immunother. Cancer 13 https:\/\/doi.org\/10.1136\/jitc-2025-012069 (2025).","DOI":"10.1136\/jitc-2025-012069"},{"key":"24779_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860\u2013867. https:\/\/doi.org\/10.1038\/ng.2699 (2013).","journal-title":"Nat. Genet."},{"key":"24779_CR15","doi-asserted-by":"publisher","first-page":"e57886","DOI":"10.1371\/journal.pone.0057886","volume":"8","author":"MB Wozniak","year":"2013","unstructured":"Wozniak, M. B. et al. Integrative genome-wide gene expression profiling of clear cell renal cell carcinoma in Czech Republic and in the united States. PLoS One. 8, e57886. https:\/\/doi.org\/10.1371\/journal.pone.0057886 (2013).","journal-title":"PLoS One"},{"key":"24779_CR16","doi-asserted-by":"publisher","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.  15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8  (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"24779_CR17","doi-asserted-by":"publisher","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14 https:\/\/doi.org\/10.1186\/1471-2105-14-7 (2013).","DOI":"10.1186\/1471-2105-14-7"},{"key":"24779_CR18","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson, E. K., Zhang, D., Reynolds, R. H., Garcia-Ruiz, S. & Ryten, M. Ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics (Oxford England) 38, 3844\u20133846. https:\/\/doi.org\/10.1093\/bioinformatics\/btac409 (2022).","journal-title":"Bioinformatics (Oxford England)"},{"key":"24779_CR19","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. Circlize implements and enhances circular visualization. Bioinformatics (Oxford England) 30, 2811\u20132812. https:\/\/doi.org\/10.1093\/bioinformatics\/btu393 (2014).","journal-title":"Bioinformatics (Oxford England)"},{"key":"24779_CR20","doi-asserted-by":"publisher","unstructured":"Berker, Y., Muti, I. H. & Cheng, L. L. Visualizing metabolomics data with R. NMR Biomed.  36, e4865. https:\/\/doi.org\/10.1002\/nbm.4865  (2023).","DOI":"10.1002\/nbm.4865"},{"key":"24779_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G., Han, Y. & He, Q. Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. Omics J. Integr. Biol. 16, 284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118 (2012).","journal-title":"Omics J. Integr. Biol."},{"key":"24779_CR22","doi-asserted-by":"publisher","unstructured":"Cheng, Q., Chen, X., Wu, H. & Du, Y. Three hematologic\/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis. J. Transl. Med. 19 https:\/\/doi.org\/10.1186\/s12967-020-02689-y (2021).","DOI":"10.1186\/s12967-020-02689-y"},{"key":"24779_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1109\/tvcg.2017.2743959","volume":"24","author":"J Gortler","year":"2018","unstructured":"Gortler, J., Schulz, C., Weiskopf, D. & Deussen, O. Bubble treemaps for uncertainty visualization. IEEE Trans. Vis. Comput. Graph. 24, 719\u2013728. https:\/\/doi.org\/10.1109\/tvcg.2017.2743959 (2018).","journal-title":"IEEE Trans. Vis. Comput. Graph."},{"key":"24779_CR24","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. Publ. Protein Soc. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"24779_CR25","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"24779_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"24779_CR27","doi-asserted-by":"publisher","unstructured":"Liu, P., Xu, H., Shi, Y., Deng, L. & Chen, X. Potential molecular mechanisms of plantain in the treatment of gout and hyperuricemia based on network pharmacology. Evid. Based Complement. Altern. Med. eCAM 2020 (3023127). https:\/\/doi.org\/10.1155\/2020\/3023127 (2020).","DOI":"10.1155\/2020\/3023127"},{"key":"24779_CR28","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1038\/s41598-022-15609-5","volume":"12","author":"Y Li","year":"2022","unstructured":"Li, Y., Lu, F. & Yin, Y. Applying logistic LASSO regression for the diagnosis of atypical crohn\u2019s disease. Sci. Rep. 12, 11340. https:\/\/doi.org\/10.1038\/s41598-022-15609-5 (2022).","journal-title":"Sci. Rep."},{"key":"24779_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341x.2000.00337.x","volume":"56","author":"PJ Heagerty","year":"2000","unstructured":"Heagerty, P. J., Lumley, T. & Pepe, M. S. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56, 337\u2013344. https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00337.x (2000).","journal-title":"Biometrics"},{"key":"24779_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scog.2017.10.001","volume":"11","author":"IS Ramsay","year":"2018","unstructured":"Ramsay, I. S. et al. Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training. Schizophrenia Res. Cogn. 11, 1\u20135. https:\/\/doi.org\/10.1016\/j.scog.2017.10.001 (2018).","journal-title":"Schizophrenia Res. Cogn."},{"key":"24779_CR31","doi-asserted-by":"publisher","unstructured":"Sachs, M. C. plotROC: a tool for plotting ROC curves. J. Stat. Softw. 79 https:\/\/doi.org\/10.18637\/jss.v079.c02 (2017).","DOI":"10.18637\/jss.v079.c02"},{"key":"24779_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong, P. et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint Blockade. Cell. Rep. 18, 248\u2013262. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019 (2017).","journal-title":"Cell. Rep."},{"key":"24779_CR33","doi-asserted-by":"publisher","unstructured":"Orifjon, S. et al. Translation and adaptation of the adult developmental coordination Disorder\/Dyspraxia checklist (ADC) into Asian Uzbekistan. Sports (Basel Switzerland) 11 https:\/\/doi.org\/10.3390\/sports11070135 (2023).","DOI":"10.3390\/sports11070135"},{"key":"24779_CR34","doi-asserted-by":"publisher","unstructured":"Shibru, B. et al. Detection of immune checkpoint receptors\u2014a current challenge in clinical flow cytometry. Front. Immunol. 12 https:\/\/doi.org\/10.3389\/fimmu.2021.694055 (2021).","DOI":"10.3389\/fimmu.2021.694055"},{"key":"24779_CR35","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1 (2018).","journal-title":"Nat. Med."},{"key":"24779_CR36","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D. C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756. https:\/\/doi.org\/10.1101\/gr.239244.118 (2018).","journal-title":"Genome Res."},{"key":"24779_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods (San Diego Calif). 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods (San Diego Calif)"},{"key":"24779_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch, E., Walker, C. L. & Rathmell, W. K. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat. Rev. Nephrol. 17, 245\u2013261. https:\/\/doi.org\/10.1038\/s41581-020-00359-2 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"24779_CR39","doi-asserted-by":"publisher","first-page":"760031","DOI":"10.3389\/fmolb.2021.760031","volume":"8","author":"B Zheng","year":"2021","unstructured":"Zheng, B. et al. Integrative analysis of immune-related genes in the tumor microenvironment of renal clear cell carcinoma and renal papillary cell carcinoma. Front. Mol. Biosci. 8, 760031. https:\/\/doi.org\/10.3389\/fmolb.2021.760031 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"24779_CR40","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.21037\/tcr-22-2782","volume":"12","author":"K Wang","year":"2023","unstructured":"Wang, K. et al. Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma. Transl. Cancer Res. 12, 1270\u20131289. https:\/\/doi.org\/10.21037\/tcr-22-2782 (2023).","journal-title":"Transl. Cancer Res."},{"key":"24779_CR41","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.18632\/aging.204922","volume":"15","author":"J Shen","year":"2023","unstructured":"Shen, J. et al. Prognostic significance and mechanisms of CXCL genes in clear cell renal cell carcinoma. Aging 15, 7974\u20137996. https:\/\/doi.org\/10.18632\/aging.204922 (2023).","journal-title":"Aging"},{"key":"24779_CR42","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.2147\/ott.S251436","volume":"13","author":"B Han","year":"2020","unstructured":"Han, B., Shaolong, E., Luan, L., Li, N. & Liu, X. CircHIPK3 promotes clear cell renal cell carcinoma (ccRCC) cells proliferation and metastasis via altering of miR-508-3p\/CXCL13 signal. OncoTargets Ther. 13, 6051\u20136062. https:\/\/doi.org\/10.2147\/ott.S251436 (2020).","journal-title":"OncoTargets Ther."},{"key":"24779_CR43","doi-asserted-by":"publisher","unstructured":"Xie, Y. et al. M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT. Cancer Cell Int. 21 https:\/\/doi.org\/10.1186\/s12935-021-02381-1 (2021).","DOI":"10.1186\/s12935-021-02381-1"},{"key":"24779_CR44","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fonc.2018.00682","volume":"8","author":"Z Zheng","year":"2018","unstructured":"Zheng, Z. et al. CXCL13\/CXCR5 axis predicts poor prognosis and promotes progression through PI3K\/AKT\/mTOR pathway in clear cell renal cell carcinoma. Front. Oncol. 8, 682. https:\/\/doi.org\/10.3389\/fonc.2018.00682 (2018).","journal-title":"Front. Oncol."},{"key":"24779_CR45","doi-asserted-by":"publisher","unstructured":"Harrer, C. et al. The CXCL13\/CXCR5 immune axis in health and disease-implications for intrathecal B cell activities in neuroinflammation. Cells   11. https:\/\/doi.org\/10.3390\/cells11172649 (2022).","DOI":"10.3390\/cells11172649"},{"key":"24779_CR46","doi-asserted-by":"publisher","first-page":"116316","DOI":"10.1016\/j.celrep.2025.116316","volume":"44","author":"S Hyslop","year":"2025","unstructured":"Hyslop, S. et al. CD7 regulates the persistence of terminally exhausted CD8\u2009+\u2009T cells during chronic infection. Cell. Rep. 44, 116316. https:\/\/doi.org\/10.1016\/j.celrep.2025.116316 (2025).","journal-title":"Cell. Rep."},{"key":"24779_CR47","doi-asserted-by":"publisher","unstructured":"Garg, G. et al. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4\u2009+\u2009CD25\u2009+\u2009regulatory T cell function. J. Immunol. (Baltimore, Md. 1950)  188, 4644\u20134653. https:\/\/doi.org\/10.4049\/jimmunol.1100272 (2012).","DOI":"10.4049\/jimmunol.1100272"},{"key":"24779_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s11684-023-1025-7","volume":"17","author":"L Liao","year":"2023","unstructured":"Liao, L., Xu, H., Zhao, Y. & Zheng, X. Metabolic interventions combined with CTLA-4 and PD-1\/PD-L1 Blockade for the treatment of tumors: mechanisms and strategies. Front. Med. 17, 805\u2013822. https:\/\/doi.org\/10.1007\/s11684-023-1025-7 (2023).","journal-title":"Front. Med."},{"key":"24779_CR49","doi-asserted-by":"publisher","unstructured":"Chan, Y. T. et al. Immune checkpoint molecules and glucose metabolism in HIV-Induced T cell exhaustion. Biomedicines 10 https:\/\/doi.org\/10.3390\/biomedicines10112809 (2022).","DOI":"10.3390\/biomedicines10112809"},{"key":"24779_CR50","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41423-022-00926-6","volume":"19","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Tumor extracellular vesicles mediate anti-PD-L1 therapy resistance by decoying anti-PD-L1. Cell Mol. Immunol. 19, 1290\u20131301. https:\/\/doi.org\/10.1038\/s41423-022-00926-6 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"24779_CR51","doi-asserted-by":"publisher","first-page":"e0297861","DOI":"10.1371\/journal.pone.0297861","volume":"19","author":"P Liu","year":"2024","unstructured":"Liu, P. et al. Causal relationship between several autoimmune diseases and renal malignancies: a two-sample Mendelian randomization study. PLoS One. 19, e0297861. https:\/\/doi.org\/10.1371\/journal.pone.0297861 (2024).","journal-title":"PLoS One"},{"key":"24779_CR52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","volume":"179","author":"DJ Clark","year":"2019","unstructured":"Clark, D. J. et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell 179, 964\u2013983e931. https:\/\/doi.org\/10.1016\/j.cell.2019.10.007 (2019).","journal-title":"Cell"},{"key":"24779_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/pap.0000000000000185","volume":"25","author":"M Akhtar","year":"2018","unstructured":"Akhtar, M., Al-Bozom, I. A. & Hussain, T. A. Molecular and metabolic basis of clear cell carcinoma of the kidney. Adv. Anat. Pathol. 25, 189\u2013196. https:\/\/doi.org\/10.1097\/pap.0000000000000185 (2018).","journal-title":"Adv. Anat. Pathol."},{"key":"24779_CR54","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cmet.2006.02.007","volume":"3","author":"MC Simon","year":"2006","unstructured":"Simon, M. C. Coming up for air: HIF-1 and mitochondrial oxygen consumption. Cell Metabol. 3, 150\u2013151. https:\/\/doi.org\/10.1016\/j.cmet.2006.02.007 (2006).","journal-title":"Cell Metabol."},{"key":"24779_CR55","doi-asserted-by":"publisher","unstructured":"Huang, L., Xie, Y., Han, W., Jiang, S. & Zeng, L. Oxidative phosphorylation-related signature participates in cancer development, and PTPRG overexpression suppresses the cancer progression in clear cell renal cell carcinoma. J. Immunol. Res. 2022, 8300187. https:\/\/doi.org\/10.1155\/2022\/8300187 (2022).","DOI":"10.1155\/2022\/8300187"},{"key":"24779_CR56","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12964-024-01677-9","volume":"22","author":"K Wei","year":"2024","unstructured":"Wei, K. et al. Mitochondrial DNA release via the mitochondrial permeability transition pore activates the cGAS-STING pathway, exacerbating inflammation in acute Kawasaki disease. Cell. Commun. Signaling CCS 22, 328. https:\/\/doi.org\/10.1186\/s12964-024-01677-9 (2024).","journal-title":"Cell. Commun. Signaling CCS"},{"key":"24779_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12964-025-02042-0","volume":"23","author":"L Giordano","year":"2025","unstructured":"Giordano, L., Ware, S. A., Lagranha, C. J. & Kaufman, B. A. Mitochondrial DNA signals driving immune responses: Why, How, where? Cell. Commun. Signaling CCS 23, 192. https:\/\/doi.org\/10.1186\/s12964-025-02042-0 (2025).","journal-title":"Cell. Commun. Signaling CCS"},{"key":"24779_CR58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11523-014-0335-8","volume":"10","author":"I Peters","year":"2015","unstructured":"Peters, I. et al. Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma. Target. Oncol. 10, 267\u2013275. https:\/\/doi.org\/10.1007\/s11523-014-0335-8 (2015).","journal-title":"Target. Oncol."},{"key":"24779_CR59","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.18632\/aging.204607","volume":"15","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma. Aging 15, 2170\u20132188. https:\/\/doi.org\/10.18632\/aging.204607 (2023).","journal-title":"Aging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24779-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24779-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:32:59Z","timestamp":1763555579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24779-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24779"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24779-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Helsinki Declaration and approved by the Scientific Research Ethics Review Committee of Shanxi Medical University (Ethics Review No: KYLL-2024-028). Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"40875"}}